These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 21233836

  • 1. An accumulation of cytogenetic and molecular genetic events characterizes the progression from MDS to secondary AML: an analysis of 38 paired samples analyzed by cytogenetics, molecular mutation analysis and SNP microarray profiling.
    Flach J, Dicker F, Schnittger S, Schindela S, Kohlmann A, Haferlach T, Kern W, Haferlach C.
    Leukemia; 2011 Apr; 25(4):713-8. PubMed ID: 21233836
    [No Abstract] [Full Text] [Related]

  • 2. Characterization of NPM1-mutated AML with a history of myelodysplastic syndromes or myeloproliferative neoplasms.
    Schnittger S, Bacher U, Haferlach C, Alpermann T, Dicker F, Sundermann J, Kern W, Haferlach T.
    Leukemia; 2011 Apr; 25(4):615-21. PubMed ID: 21233837
    [Abstract] [Full Text] [Related]

  • 3. Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases.
    Ok CY, Patel KP, Garcia-Manero G, Routbort MJ, Fu B, Tang G, Goswami M, Singh R, Kanagal-Shamanna R, Pierce SA, Young KH, Kantarjian HM, Medeiros LJ, Luthra R, Wang SA.
    Leuk Res; 2015 Mar; 39(3):348-54. PubMed ID: 25573287
    [Abstract] [Full Text] [Related]

  • 4. DNA profiling by arrayCGH in acute myeloid leukemia and myelodysplastic syndromes.
    Suela J, Alvarez S, Cigudosa JC.
    Cytogenet Genome Res; 2007 Mar; 118(2-4):304-9. PubMed ID: 18000384
    [Abstract] [Full Text] [Related]

  • 5. Single nucleotide polymorphism array-based karyotyping in acute myeloid leukemia or myelodysplastic syndrome with trisomy 8 as the sole chromosomal abnormality.
    Hahm C, Mun YC, Seong CM, Han SH, Chung WS, Huh J.
    Acta Haematol; 2013 Mar; 129(3):154-8. PubMed ID: 23208021
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Replication errors in hematological neoplasias: genomic instability in progression of disease is different among different types of leukemia.
    Ohyashiki JH, Ohyashiki K, Aizawa S, Kawakubo K, Shimamoto T, Iwama H, Hayashi S, Toyama K.
    Clin Cancer Res; 1996 Sep; 2(9):1583-9. PubMed ID: 9816337
    [Abstract] [Full Text] [Related]

  • 8. Aberrant DNA methylation is a dominant mechanism in MDS progression to AML.
    Jiang Y, Dunbar A, Gondek LP, Mohan S, Rataul M, O'Keefe C, Sekeres M, Saunthararajah Y, Maciejewski JP.
    Blood; 2009 Feb 05; 113(6):1315-25. PubMed ID: 18832655
    [Abstract] [Full Text] [Related]

  • 9. Molecular cytogenetic profiling of complex karyotypes in primary myelodysplastic syndromes and acute myeloid leukemia.
    Trost D, Hildebrandt B, Beier M, Müller N, Germing U, Royer-Pokora B.
    Cancer Genet Cytogenet; 2006 Feb 05; 165(1):51-63. PubMed ID: 16490597
    [Abstract] [Full Text] [Related]

  • 10. [Flt-3/ITD mutation in pediatric leukemia and its clinical significance].
    Wang J, Wang T, Li S, Lin L, Gang Y.
    Ai Zheng; 2007 Jan 05; 26(1):58-63. PubMed ID: 17222369
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Proteomic analysis of childhood de novo acute myeloid leukemia and myelodysplastic syndrome/AML: correlation to molecular and cytogenetic analyses.
    Braoudaki M, Tzortzatou-Stathopoulou F, Anagnostopoulos AK, Papathanassiou C, Vougas K, Karamolegou K, Tsangaris GT.
    Amino Acids; 2011 Mar 05; 40(3):943-51. PubMed ID: 20711619
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cytogenetic evolution following the transformation of myelodysplastic syndrome to acute myelogenous leukemia: implications on the overlap between the two diseases.
    Ghaddar HM, Stass SA, Pierce S, Estey EH.
    Leukemia; 1994 Oct 05; 8(10):1649-53. PubMed ID: 7934160
    [Abstract] [Full Text] [Related]

  • 16. FLT3 and NPM1 mutations in myelodysplastic syndromes: Frequency and potential value for predicting progression to acute myeloid leukemia.
    Bains A, Luthra R, Medeiros LJ, Zuo Z.
    Am J Clin Pathol; 2011 Jan 05; 135(1):62-9. PubMed ID: 21173125
    [Abstract] [Full Text] [Related]

  • 17. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001.
    Mauritzson N, Albin M, Rylander L, Billström R, Ahlgren T, Mikoczy Z, Björk J, Strömberg U, Nilsson PG, Mitelman F, Hagmar L, Johansson B.
    Leukemia; 2002 Dec 05; 16(12):2366-78. PubMed ID: 12454741
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Molecular characterisation of a recurrent, semi-cryptic RUNX1 translocation t(7;21) in myelodysplastic syndrome and acute myeloid leukaemia.
    Foster N, Paulsson K, Sales M, Cunningham J, Groves M, O'Connor N, Begum S, Stubbs T, McMullan DJ, Griffiths M, Pratt N, Tauro S.
    Br J Haematol; 2010 Mar 05; 148(6):938-43. PubMed ID: 20064152
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.